

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 4.68301911 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.38347178 |
| 3 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.11678609 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.03339720 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 3.90636473 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.90636473 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.90636473 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.90636473 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 3.90636473 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 3.90636473 |
| 11 | detection of external biotic stimulus (GO:0098581) | 3.68644704 |
| 12 | cell adhesion mediated by integrin (GO:0033627) | 3.62559262 |
| 13 | detection of other organism (GO:0098543) | 3.57407251 |
| 14 | protein localization to endosome (GO:0036010) | 3.56037035 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.55721480 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.55721480 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.35165085 |
| 18 | microglial cell activation (GO:0001774) | 3.26372263 |
| 19 | response to lipoprotein particle (GO:0055094) | 3.13998299 |
| 20 | hypotonic response (GO:0006971) | 3.12980595 |
| 21 | detection of biotic stimulus (GO:0009595) | 3.12292809 |
| 22 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08180008 |
| 23 | response to laminar fluid shear stress (GO:0034616) | 3.05795728 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.04861694 |
| 25 | negative regulation of interleukin-12 production (GO:0032695) | 3.04746782 |
| 26 | detection of bacterium (GO:0016045) | 2.99369476 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 2.95920497 |
| 28 | positive regulation of macrophage cytokine production (GO:0060907) | 2.91885182 |
| 29 | embryonic process involved in female pregnancy (GO:0060136) | 2.88561921 |
| 30 | positive regulation of receptor recycling (GO:0001921) | 2.85937434 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.85017125 |
| 32 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.81657472 |
| 33 | regulation of leukocyte degranulation (GO:0043300) | 2.78945214 |
| 34 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.78918627 |
| 35 | germinal center formation (GO:0002467) | 2.78853064 |
| 36 | cortical actin cytoskeleton organization (GO:0030866) | 2.78084312 |
| 37 | growth hormone receptor signaling pathway (GO:0060396) | 2.77709347 |
| 38 | regulation of early endosome to late endosome transport (GO:2000641) | 2.75379578 |
| 39 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.72637291 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 2.72334129 |
| 41 | neutrophil activation involved in immune response (GO:0002283) | 2.71454453 |
| 42 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.69493449 |
| 43 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.69096504 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.68923419 |
| 45 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.67029311 |
| 46 | apoptotic cell clearance (GO:0043277) | 2.66404403 |
| 47 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.64755607 |
| 48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.63355642 |
| 49 | I-kappaB phosphorylation (GO:0007252) | 2.62399462 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.62368107 |
| 51 | cortical cytoskeleton organization (GO:0030865) | 2.62088889 |
| 52 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.59570274 |
| 53 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.57883474 |
| 54 | mannose metabolic process (GO:0006013) | 2.56042093 |
| 55 | positive regulation of interferon-alpha production (GO:0032727) | 2.55711545 |
| 56 | macrophage activation (GO:0042116) | 2.55192317 |
| 57 | substrate-dependent cell migration (GO:0006929) | 2.54489695 |
| 58 | response to fluid shear stress (GO:0034405) | 2.53874456 |
| 59 | regulation of necroptotic process (GO:0060544) | 2.53680435 |
| 60 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.52555168 |
| 61 | regulation of interferon-alpha production (GO:0032647) | 2.52086064 |
| 62 | regulation of macrophage cytokine production (GO:0010935) | 2.51874856 |
| 63 | virion attachment to host cell (GO:0019062) | 2.50431888 |
| 64 | adhesion of symbiont to host cell (GO:0044650) | 2.50431888 |
| 65 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.50281521 |
| 66 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.50099503 |
| 67 | regulation of chemokine secretion (GO:0090196) | 2.48935465 |
| 68 | barbed-end actin filament capping (GO:0051016) | 2.48720674 |
| 69 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.48653775 |
| 70 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.48413323 |
| 71 | negative regulation of granulocyte differentiation (GO:0030853) | 2.48112051 |
| 72 | positive regulation of p38MAPK cascade (GO:1900745) | 2.46946305 |
| 73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.45509206 |
| 74 | myeloid cell activation involved in immune response (GO:0002275) | 2.43473662 |
| 75 | Rap protein signal transduction (GO:0032486) | 2.42546362 |
| 76 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.42047740 |
| 77 | low-density lipoprotein particle clearance (GO:0034383) | 2.40651544 |
| 78 | germ cell migration (GO:0008354) | 2.40331007 |
| 79 | T-helper 1 type immune response (GO:0042088) | 2.40221717 |
| 80 | cellular response to growth hormone stimulus (GO:0071378) | 2.38466348 |
| 81 | wound healing, spreading of epidermal cells (GO:0035313) | 2.38448291 |
| 82 | positive regulation of leukocyte degranulation (GO:0043302) | 2.37426027 |
| 83 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.36651021 |
| 84 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.35953025 |
| 85 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.35429787 |
| 86 | response to host immune response (GO:0052572) | 2.35429787 |
| 87 | response to thyroid hormone (GO:0097066) | 2.34753577 |
| 88 | cellular extravasation (GO:0045123) | 2.33814727 |
| 89 | negative regulation of type 2 immune response (GO:0002829) | 2.31809474 |
| 90 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.31745116 |
| 91 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.31391688 |
| 92 | establishment of endothelial barrier (GO:0061028) | 2.30796201 |
| 93 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.30403881 |
| 94 | positive regulation of chemokine secretion (GO:0090197) | 2.29442981 |
| 95 | regulation of regulated secretory pathway (GO:1903305) | 2.29275397 |
| 96 | negative regulation of T cell mediated immunity (GO:0002710) | 2.29208787 |
| 97 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.28200778 |
| 98 | neutrophil mediated immunity (GO:0002446) | 2.28176698 |
| 99 | skin morphogenesis (GO:0043589) | 2.27769389 |
| 100 | regulation of cholesterol storage (GO:0010885) | 2.25600661 |
| 101 | surfactant homeostasis (GO:0043129) | 2.25464209 |
| 102 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.24442150 |
| 103 | B cell receptor signaling pathway (GO:0050853) | 2.23683580 |
| 104 | positive regulation of mast cell activation (GO:0033005) | 2.19972787 |
| 105 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.19806938 |
| 106 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.19766526 |
| 107 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.19526337 |
| 108 | negative regulation of lipid storage (GO:0010888) | 2.18891859 |
| 109 | myelin maintenance (GO:0043217) | 2.18380557 |
| 110 | COPI coating of Golgi vesicle (GO:0048205) | 2.18308264 |
| 111 | Golgi transport vesicle coating (GO:0048200) | 2.18308264 |
| 112 | positive regulation of B cell differentiation (GO:0045579) | 2.17535503 |
| 113 | neutrophil activation (GO:0042119) | 2.17335090 |
| 114 | nuclear pore complex assembly (GO:0051292) | 2.16285420 |
| 115 | integrin-mediated signaling pathway (GO:0007229) | 2.15622437 |
| 116 | glycosphingolipid catabolic process (GO:0046479) | 2.15164685 |
| 117 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.14473826 |
| 118 | response to host (GO:0075136) | 2.14213339 |
| 119 | response to host defenses (GO:0052200) | 2.14213339 |
| 120 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.14213339 |
| 121 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.14211965 |
| 122 | stress fiber assembly (GO:0043149) | 2.13254500 |
| 123 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.13254283 |
| 124 | ruffle organization (GO:0031529) | 2.12686507 |
| 125 | positive regulation of regulated secretory pathway (GO:1903307) | 2.12568009 |
| 126 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.10739010 |
| 127 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.09940251 |
| 128 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.09452983 |
| 129 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.08919489 |
| 130 | response to muramyl dipeptide (GO:0032495) | 2.08189592 |
| 131 | regulation of macrophage chemotaxis (GO:0010758) | 2.07842225 |
| 132 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.07764421 |
| 133 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.07361912 |
| 134 | phagocytosis, engulfment (GO:0006911) | 2.07212574 |
| 135 | negative regulation of fatty acid transport (GO:2000192) | 2.06371812 |
| 136 | heterotypic cell-cell adhesion (GO:0034113) | 2.05921055 |
| 137 | granulocyte activation (GO:0036230) | 2.05388937 |
| 138 | membrane raft organization (GO:0031579) | 2.05123534 |
| 139 | adhesion of symbiont to host (GO:0044406) | 2.04450483 |
| 140 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.03663094 |
| 141 | glomerular filtration (GO:0003094) | 2.03460703 |
| 142 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.01985102 |
| 143 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.01807978 |
| 144 | mesodermal cell differentiation (GO:0048333) | 2.00879303 |
| 145 | pinocytosis (GO:0006907) | 2.00311179 |
| 146 | negative regulation of B cell proliferation (GO:0030889) | 1.99912938 |
| 147 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 1.99594431 |
| 148 | renal filtration (GO:0097205) | 1.98644549 |
| 149 | glomerular visceral epithelial cell development (GO:0072015) | 1.97049273 |
| 150 | positive regulation of antigen processing and presentation (GO:0002579) | 1.96595359 |
| 151 | wound healing, spreading of cells (GO:0044319) | 1.96518568 |
| 152 | positive regulation of lipid kinase activity (GO:0090218) | 1.96066208 |
| 153 | bone remodeling (GO:0046849) | 1.95946431 |
| 154 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 1.95739859 |
| 155 | nerve growth factor signaling pathway (GO:0038180) | 1.94907076 |
| 156 | hepatocyte apoptotic process (GO:0097284) | 1.94821225 |
| 157 | positive regulation of osteoblast proliferation (GO:0033690) | 1.94640193 |
| 158 | regulation of antigen processing and presentation (GO:0002577) | 1.94448145 |
| 159 | response to peptidoglycan (GO:0032494) | 1.94098164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.73467921 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.08858755 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65568802 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.60527880 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.50304605 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.45356700 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.45296658 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.37435265 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.32256129 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.09123492 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.08773135 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07098109 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.05514092 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93676823 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93400969 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.93051571 |
| 17 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.89084779 |
| 18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83713233 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.83671747 |
| 20 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.80870983 |
| 21 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.79701683 |
| 22 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.79693895 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.79397216 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75423082 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.74573531 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73399426 |
| 27 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73325882 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71560142 |
| 29 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.70593283 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.70588905 |
| 31 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.70190838 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.69388148 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69318681 |
| 34 | CJUN_26792858_Chip-Seq_BT549_Human | 1.68527732 |
| 35 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59098893 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57789429 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56710176 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56220750 |
| 39 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53679242 |
| 40 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50059946 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.49953015 |
| 42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.49953015 |
| 43 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.49449253 |
| 44 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48960930 |
| 45 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48304912 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47748932 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44618950 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.43906472 |
| 49 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.42356069 |
| 50 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40798436 |
| 51 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.40044581 |
| 52 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.37733836 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.37581602 |
| 54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.36551606 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36177714 |
| 56 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35289900 |
| 57 | TP53_16413492_ChIP-PET_HCT116_Human | 1.34871286 |
| 58 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34375728 |
| 59 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.33908399 |
| 60 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32238423 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31828139 |
| 62 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31768487 |
| 63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.30904858 |
| 64 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.29272161 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26319686 |
| 66 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25629110 |
| 67 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24404611 |
| 68 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.24154016 |
| 69 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22492807 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21640431 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20189012 |
| 72 | MYB_26560356_Chip-Seq_TH1_Human | 1.19896701 |
| 73 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19740627 |
| 74 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19640707 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19264523 |
| 76 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.19062154 |
| 77 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.19062154 |
| 78 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18985956 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.18641305 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16807541 |
| 81 | MYB_26560356_Chip-Seq_TH2_Human | 1.16528827 |
| 82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15801363 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13898131 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12733932 |
| 85 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11428096 |
| 86 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11289411 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.10844128 |
| 88 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10623030 |
| 89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09297811 |
| 90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09266221 |
| 91 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08501462 |
| 92 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06836757 |
| 93 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.06655857 |
| 94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06566392 |
| 95 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.06368443 |
| 96 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06354990 |
| 97 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06175550 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05489745 |
| 99 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04466655 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04141832 |
| 101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03733631 |
| 102 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03558826 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03549495 |
| 104 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02996283 |
| 105 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.02976893 |
| 106 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02831224 |
| 107 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02100954 |
| 108 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.02061774 |
| 109 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01578719 |
| 110 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01382315 |
| 111 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01267741 |
| 112 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00676328 |
| 113 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99817807 |
| 114 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99596435 |
| 115 | UTX_26944678_Chip-Seq_JUKART_Human | 0.99112268 |
| 116 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98816225 |
| 117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98543766 |
| 118 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97764997 |
| 119 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97637241 |
| 120 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97377634 |
| 121 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97056952 |
| 122 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96914445 |
| 123 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.95487996 |
| 124 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92857221 |
| 125 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91761811 |
| 126 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90046565 |
| 127 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88646889 |
| 128 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88529564 |
| 129 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88324237 |
| 130 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.87407318 |
| 131 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86768324 |
| 132 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85844152 |
| 133 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85828469 |
| 134 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.85236378 |
| 135 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.85221661 |
| 136 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84166769 |
| 137 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84166769 |
| 138 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84035620 |
| 139 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.83899876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.93608107 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.26796862 |
| 3 | MP0005451_abnormal_body_composition | 2.77004934 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.76333925 |
| 5 | MP0003303_peritoneal_inflammation | 2.48158082 |
| 6 | MP0003690_abnormal_glial_cell | 2.33774689 |
| 7 | MP0003566_abnormal_cell_adhesion | 2.29044131 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.28528978 |
| 9 | MP0008260_abnormal_autophagy | 2.19991768 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.06965126 |
| 11 | MP0000920_abnormal_myelination | 2.04747076 |
| 12 | MP0005275_abnormal_skin_tensile | 2.03336975 |
| 13 | MP0006082_CNS_inflammation | 2.03239412 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.02111831 |
| 15 | MP0005167_abnormal_blood-brain_barrier | 1.97481708 |
| 16 | MP0003950_abnormal_plasma_membrane | 1.96204813 |
| 17 | MP0004272_abnormal_basement_membrane | 1.93756869 |
| 18 | MP0003436_decreased_susceptibility_to | 1.88815931 |
| 19 | MP0001835_abnormal_antigen_presentation | 1.88623586 |
| 20 | MP0003724_increased_susceptibility_to | 1.86694566 |
| 21 | MP0003091_abnormal_cell_migration | 1.85799888 |
| 22 | MP0001958_emphysema | 1.85126341 |
| 23 | MP0003279_aneurysm | 1.80611953 |
| 24 | MP0002419_abnormal_innate_immunity | 1.78646158 |
| 25 | MP0005623_abnormal_meninges_morphology | 1.75111577 |
| 26 | MP0003828_pulmonary_edema | 1.70434070 |
| 27 | MP0000858_altered_metastatic_potential | 1.68123776 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.64049315 |
| 29 | MP0003045_fibrosis | 1.62556100 |
| 30 | MP0003448_altered_tumor_morphology | 1.61238616 |
| 31 | MP0002998_abnormal_bone_remodeling | 1.60778268 |
| 32 | MP0005409_darkened_coat_color | 1.60598332 |
| 33 | MP0001879_abnormal_lymphatic_vessel | 1.55050991 |
| 34 | MP0000733_abnormal_muscle_development | 1.54726036 |
| 35 | MP0004883_abnormal_blood_vessel | 1.52874005 |
| 36 | MP0000767_abnormal_smooth_muscle | 1.51415884 |
| 37 | MP0005171_absent_coat_pigmentation | 1.50196667 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.48762481 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.48219636 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.48077157 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.47571395 |
| 42 | MP0002009_preneoplasia | 1.45074088 |
| 43 | MP0010678_abnormal_skin_adnexa | 1.43846296 |
| 44 | MP0005387_immune_system_phenotype | 1.43394733 |
| 45 | MP0001790_abnormal_immune_system | 1.43394733 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.42791884 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.42791884 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.42044881 |
| 49 | MP0009278_abnormal_bone_marrow | 1.41635701 |
| 50 | MP0004510_myositis | 1.39053364 |
| 51 | MP0003075_altered_response_to | 1.34437274 |
| 52 | MP0002006_tumorigenesis | 1.32854013 |
| 53 | MP0000343_altered_response_to | 1.32853897 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.31254153 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.29150850 |
| 56 | MP0001851_eye_inflammation | 1.28213625 |
| 57 | MP0002295_abnormal_pulmonary_circulatio | 1.26650982 |
| 58 | MP0002452_abnormal_antigen_presenting | 1.26328711 |
| 59 | MP0005257_abnormal_intraocular_pressure | 1.19295570 |
| 60 | MP0004947_skin_inflammation | 1.19009598 |
| 61 | MP0008004_abnormal_stomach_pH | 1.17335613 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.17272014 |
| 63 | MP0004185_abnormal_adipocyte_glucose | 1.16262620 |
| 64 | MP0006054_spinal_hemorrhage | 1.15499703 |
| 65 | MP0000383_abnormal_hair_follicle | 1.15368196 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.15300324 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 1.14286262 |
| 68 | MP0003329_amyloid_beta_deposits | 1.13013819 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.12566536 |
| 70 | MP0002254_reproductive_system_inflammat | 1.12424011 |
| 71 | MP0005025_abnormal_response_to | 1.10484353 |
| 72 | MP0005023_abnormal_wound_healing | 1.09002720 |
| 73 | MP0009840_abnormal_foam_cell | 1.08492534 |
| 74 | MP0002396_abnormal_hematopoietic_system | 1.08249892 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.08007963 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 1.07773640 |
| 77 | MP0000604_amyloidosis | 1.07103967 |
| 78 | MP0005503_abnormal_tendon_morphology | 1.06815778 |
| 79 | MP0001915_intracranial_hemorrhage | 1.05813345 |
| 80 | MP0004130_abnormal_muscle_cell | 1.04412151 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 1.04006567 |
| 82 | MP0002405_respiratory_system_inflammati | 1.03793201 |
| 83 | MP0002896_abnormal_bone_mineralization | 1.03096634 |
| 84 | MP0001845_abnormal_inflammatory_respons | 1.02870192 |
| 85 | MP0005388_respiratory_system_phenotype | 1.00510333 |
| 86 | MP0002133_abnormal_respiratory_system | 1.00510333 |
| 87 | MP0005671_abnormal_response_to | 1.00299607 |
| 88 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98970522 |
| 89 | MP0002723_abnormal_immune_serum | 0.98227326 |
| 90 | MP0005390_skeleton_phenotype | 0.97504585 |
| 91 | MP0002398_abnormal_bone_marrow | 0.97374936 |
| 92 | MP0001800_abnormal_humoral_immune | 0.96216850 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.95864935 |
| 94 | MP0005164_abnormal_response_to | 0.95353927 |
| 95 | MP0000249_abnormal_blood_vessel | 0.94840628 |
| 96 | MP0000685_abnormal_immune_system | 0.94190842 |
| 97 | MP0002168_other_aberrant_phenotype | 0.93648790 |
| 98 | MP0003252_abnormal_bile_duct | 0.93120383 |
| 99 | MP0001853_heart_inflammation | 0.92746197 |
| 100 | MP0005670_abnormal_white_adipose | 0.92192384 |
| 101 | MP0004134_abnormal_chest_morphology | 0.91176702 |
| 102 | MP0005166_decreased_susceptibility_to | 0.91095636 |
| 103 | MP0000716_abnormal_immune_system | 0.89462411 |
| 104 | MP0004264_abnormal_extraembryonic_tissu | 0.88782230 |
| 105 | MP0002060_abnormal_skin_morphology | 0.88657403 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.87814805 |
| 107 | MP0001819_abnormal_immune_cell | 0.87602610 |
| 108 | MP0003763_abnormal_thymus_physiology | 0.87582671 |
| 109 | MP0005375_adipose_tissue_phenotype | 0.87493964 |
| 110 | MP0009115_abnormal_fat_cell | 0.86772611 |
| 111 | MP0002420_abnormal_adaptive_immunity | 0.86637156 |
| 112 | MP0008469_abnormal_protein_level | 0.86492422 |
| 113 | MP0002971_abnormal_brown_adipose | 0.85618227 |
| 114 | MP0002933_joint_inflammation | 0.83025238 |
| 115 | MP0005621_abnormal_cell_physiology | 0.82353537 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.82238792 |
| 117 | MP0009764_decreased_sensitivity_to | 0.81314118 |
| 118 | MP0002722_abnormal_immune_system | 0.81122604 |
| 119 | MP0004233_abnormal_muscle_weight | 0.80151945 |
| 120 | MP0001614_abnormal_blood_vessel | 0.79721656 |
| 121 | MP0010155_abnormal_intestine_physiology | 0.79302082 |
| 122 | MP0009785_altered_susceptibility_to | 0.78852755 |
| 123 | MP0002128_abnormal_blood_circulation | 0.78191448 |
| 124 | MP0003795_abnormal_bone_structure | 0.77878892 |
| 125 | MP0002928_abnormal_bile_duct | 0.75958780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 3.75430592 |
| 2 | Premature rupture of membranes (HP:0001788) | 3.55896130 |
| 3 | Cerebral aneurysm (HP:0004944) | 3.42857754 |
| 4 | Hematochezia (HP:0002573) | 3.40758817 |
| 5 | Axonal loss (HP:0003447) | 3.29504278 |
| 6 | Aortic dissection (HP:0002647) | 3.24704275 |
| 7 | Osteolytic defects of the hand bones (HP:0009699) | 3.17856375 |
| 8 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.17856375 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.15354788 |
| 10 | Arterial tortuosity (HP:0005116) | 3.13117131 |
| 11 | Vascular tortuosity (HP:0004948) | 3.12773545 |
| 12 | Polycythemia (HP:0001901) | 3.08073196 |
| 13 | Thick nail (HP:0001805) | 3.05881117 |
| 14 | Aortic aneurysm (HP:0004942) | 3.05588849 |
| 15 | Glomerulonephritis (HP:0000099) | 3.04151740 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.02371810 |
| 17 | Myocardial infarction (HP:0001658) | 2.95927353 |
| 18 | Peritonitis (HP:0002586) | 2.95223722 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 2.81856948 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 2.71090572 |
| 21 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.63947251 |
| 22 | Mitral valve prolapse (HP:0001634) | 2.59272114 |
| 23 | Nephritis (HP:0000123) | 2.46052440 |
| 24 | Ankyloglossia (HP:0010296) | 2.45772726 |
| 25 | Shallow orbits (HP:0000586) | 2.45500031 |
| 26 | Disproportionate tall stature (HP:0001519) | 2.42995040 |
| 27 | Disinhibition (HP:0000734) | 2.42912261 |
| 28 | Atrophic scars (HP:0001075) | 2.41205501 |
| 29 | Orchitis (HP:0100796) | 2.32769990 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 2.32323631 |
| 31 | Abnormality of macrophages (HP:0004311) | 2.32237474 |
| 32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30582501 |
| 33 | Optic neuritis (HP:0100653) | 2.29656095 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.29656095 |
| 35 | Persistence of primary teeth (HP:0006335) | 2.28033005 |
| 36 | Peripheral demyelination (HP:0011096) | 2.27853052 |
| 37 | Hypoplasia of the iris (HP:0007676) | 2.27280133 |
| 38 | Increased CSF protein (HP:0002922) | 2.26150301 |
| 39 | Increased connective tissue (HP:0009025) | 2.24715680 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 2.20001057 |
| 41 | Dilatation of the ascending aorta (HP:0005111) | 2.17925892 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.17292422 |
| 43 | Complement deficiency (HP:0004431) | 2.16822693 |
| 44 | Broad metatarsal (HP:0001783) | 2.15491716 |
| 45 | Gingival bleeding (HP:0000225) | 2.13997395 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11144048 |
| 47 | Metabolic alkalosis (HP:0200114) | 2.09488774 |
| 48 | Abnormality of oral frenula (HP:0000190) | 2.09353393 |
| 49 | Myositis (HP:0100614) | 2.07673280 |
| 50 | Scapular winging (HP:0003691) | 2.07317961 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.06680881 |
| 52 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04745096 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.03801848 |
| 54 | Thin bony cortex (HP:0002753) | 2.03097818 |
| 55 | Neurofibrillary tangles (HP:0002185) | 2.02513652 |
| 56 | Abnormality of the peritoneum (HP:0002585) | 1.99101834 |
| 57 | Obstructive lung disease (HP:0006536) | 1.98898204 |
| 58 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98898204 |
| 59 | Vertebral compression fractures (HP:0002953) | 1.97896086 |
| 60 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96486545 |
| 61 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96486545 |
| 62 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96486545 |
| 63 | Protrusio acetabuli (HP:0003179) | 1.95487076 |
| 64 | Abnormality of complement system (HP:0005339) | 1.93180039 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 1.93164450 |
| 66 | Absent frontal sinuses (HP:0002688) | 1.92888998 |
| 67 | Prostate neoplasm (HP:0100787) | 1.92544394 |
| 68 | Recurrent fungal infections (HP:0002841) | 1.90391724 |
| 69 | Onion bulb formation (HP:0003383) | 1.89221009 |
| 70 | Slow saccadic eye movements (HP:0000514) | 1.88887434 |
| 71 | Amyloidosis (HP:0011034) | 1.87605943 |
| 72 | Mediastinal lymphadenopathy (HP:0100721) | 1.86642638 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 1.86115818 |
| 74 | Arterial thrombosis (HP:0004420) | 1.85393251 |
| 75 | Increased IgE level (HP:0003212) | 1.84509226 |
| 76 | Hyporeflexia of lower limbs (HP:0002600) | 1.84343335 |
| 77 | Vacuolated lymphocytes (HP:0001922) | 1.84067822 |
| 78 | Epistaxis (HP:0000421) | 1.84028630 |
| 79 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.83536582 |
| 80 | Wormian bones (HP:0002645) | 1.83389255 |
| 81 | Submucous cleft hard palate (HP:0000176) | 1.81582247 |
| 82 | Decreased motor nerve conduction velocity (HP:0003431) | 1.80522538 |
| 83 | Gingivitis (HP:0000230) | 1.80346567 |
| 84 | Urticaria (HP:0001025) | 1.79958427 |
| 85 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.78197349 |
| 86 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.78197349 |
| 87 | Osteomyelitis (HP:0002754) | 1.77648476 |
| 88 | Macroorchidism (HP:0000053) | 1.77000134 |
| 89 | Prolonged bleeding time (HP:0003010) | 1.76758869 |
| 90 | Increased variability in muscle fiber diameter (HP:0003557) | 1.76679089 |
| 91 | Recurrent skin infections (HP:0001581) | 1.76172474 |
| 92 | Fragile skin (HP:0001030) | 1.76157774 |
| 93 | Aneurysm (HP:0002617) | 1.75948718 |
| 94 | Esophageal varix (HP:0002040) | 1.75770738 |
| 95 | Spondylolisthesis (HP:0003302) | 1.74164611 |
| 96 | Soft skin (HP:0000977) | 1.73793366 |
| 97 | T lymphocytopenia (HP:0005403) | 1.73703639 |
| 98 | Muscle fiber splitting (HP:0003555) | 1.73002560 |
| 99 | Fatigue (HP:0012378) | 1.72764781 |
| 100 | Metaphyseal cupping (HP:0003021) | 1.72446216 |
| 101 | Hypokalemic alkalosis (HP:0001949) | 1.72141447 |
| 102 | Loss of speech (HP:0002371) | 1.71228246 |
| 103 | Abnormality of the frontal sinuses (HP:0002687) | 1.70392380 |
| 104 | Keratoconjunctivitis (HP:0001096) | 1.70264863 |
| 105 | Subacute progressive viral hepatitis (HP:0006572) | 1.69140605 |
| 106 | Colitis (HP:0002583) | 1.68725582 |
| 107 | Femoral bowing (HP:0002980) | 1.67919455 |
| 108 | Hypoplastic ischia (HP:0003175) | 1.66952911 |
| 109 | Abnormality of chloride homeostasis (HP:0011422) | 1.66866832 |
| 110 | Mucopolysacchariduria (HP:0008155) | 1.66455514 |
| 111 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.66455514 |
| 112 | Coarse hair (HP:0002208) | 1.65981073 |
| 113 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.65371433 |
| 114 | Overgrowth (HP:0001548) | 1.64916525 |
| 115 | Blue sclerae (HP:0000592) | 1.64261458 |
| 116 | Syringomyelia (HP:0003396) | 1.64107190 |
| 117 | Spinal cord lesions (HP:0100561) | 1.64107190 |
| 118 | Abnormality of proline metabolism (HP:0010907) | 1.63943303 |
| 119 | Hydroxyprolinuria (HP:0003080) | 1.63943303 |
| 120 | Recurrent cutaneous fungal infections (HP:0011370) | 1.63742373 |
| 121 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.63742373 |
| 122 | Periodontitis (HP:0000704) | 1.63357480 |
| 123 | Cerebral inclusion bodies (HP:0100314) | 1.62673653 |
| 124 | Papillary thyroid carcinoma (HP:0002895) | 1.61437914 |
| 125 | Tetany (HP:0001281) | 1.61174518 |
| 126 | Follicular hyperkeratosis (HP:0007502) | 1.60361054 |
| 127 | Mitral stenosis (HP:0001718) | 1.60217590 |
| 128 | Buphthalmos (HP:0000557) | 1.59587601 |
| 129 | Bone pain (HP:0002653) | 1.59342028 |
| 130 | Abnormality of the common coagulation pathway (HP:0010990) | 1.58801744 |
| 131 | Hemoptysis (HP:0002105) | 1.58471619 |
| 132 | Viral hepatitis (HP:0006562) | 1.58411463 |
| 133 | Chest pain (HP:0100749) | 1.58039947 |
| 134 | Increased mean platelet volume (HP:0011877) | 1.57890402 |
| 135 | Orthostatic hypotension (HP:0001278) | 1.57237681 |
| 136 | Difficulty running (HP:0009046) | 1.56495222 |
| 137 | Pathologic fracture (HP:0002756) | 1.56256575 |
| 138 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.56114010 |
| 139 | Asymmetry of the thorax (HP:0001555) | 1.56036878 |
| 140 | Tibial bowing (HP:0002982) | 1.55829867 |
| 141 | Abnormal platelet volume (HP:0011876) | 1.55409296 |
| 142 | Cellulitis (HP:0100658) | 1.55409026 |
| 143 | Termporal pattern (HP:0011008) | 1.55075022 |
| 144 | Insidious onset (HP:0003587) | 1.55075022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 3.78879181 |
| 2 | TGFBR2 | 3.54890978 |
| 3 | EPHB1 | 3.19570190 |
| 4 | PRPF4B | 2.99358762 |
| 5 | KSR2 | 2.52145078 |
| 6 | ERN1 | 2.38519076 |
| 7 | CAMK1D | 2.33149990 |
| 8 | MAP3K14 | 2.31949674 |
| 9 | STK39 | 2.21016335 |
| 10 | RIPK1 | 2.16350265 |
| 11 | CAMK1G | 2.15099846 |
| 12 | TTN | 1.93495441 |
| 13 | TRPM7 | 1.72035516 |
| 14 | BMX | 1.70630357 |
| 15 | MAP3K13 | 1.60695856 |
| 16 | MAP3K6 | 1.59019956 |
| 17 | BMPR2 | 1.58067588 |
| 18 | ZAP70 | 1.56562383 |
| 19 | CLK1 | 1.54450352 |
| 20 | EPHA3 | 1.52069894 |
| 21 | KSR1 | 1.47526269 |
| 22 | MAP3K1 | 1.46128010 |
| 23 | LATS1 | 1.43807315 |
| 24 | JAK1 | 1.43311032 |
| 25 | OXSR1 | 1.40801216 |
| 26 | STK10 | 1.40558542 |
| 27 | WNK1 | 1.39400447 |
| 28 | FGFR2 | 1.34791642 |
| 29 | STK3 | 1.31539632 |
| 30 | PTK6 | 1.30593842 |
| 31 | ICK | 1.28640963 |
| 32 | FRK | 1.28222411 |
| 33 | MAPK15 | 1.27109549 |
| 34 | CSK | 1.24890789 |
| 35 | TYK2 | 1.24589998 |
| 36 | GRK7 | 1.24382759 |
| 37 | MET | 1.23615823 |
| 38 | PDGFRB | 1.23547579 |
| 39 | NEK9 | 1.23027696 |
| 40 | DMPK | 1.22122654 |
| 41 | YES1 | 1.20368683 |
| 42 | FGR | 1.14111074 |
| 43 | BLK | 1.13851618 |
| 44 | CDK6 | 1.12029902 |
| 45 | TBK1 | 1.11973707 |
| 46 | LATS2 | 1.09160083 |
| 47 | WNK4 | 1.08556281 |
| 48 | MAP3K2 | 1.08437692 |
| 49 | IRAK4 | 1.07708827 |
| 50 | RAF1 | 1.07236981 |
| 51 | PKN1 | 1.06888331 |
| 52 | RET | 1.04988857 |
| 53 | IKBKB | 1.02629890 |
| 54 | TEC | 1.02588792 |
| 55 | CSF1R | 1.00290876 |
| 56 | FGFR3 | 0.99987119 |
| 57 | ITK | 0.99276991 |
| 58 | MAP3K3 | 0.99061901 |
| 59 | MARK2 | 0.96779668 |
| 60 | FES | 0.96472294 |
| 61 | PKN2 | 0.96442613 |
| 62 | PIK3CA | 0.96066393 |
| 63 | NUAK1 | 0.95493473 |
| 64 | IRAK3 | 0.95354967 |
| 65 | MST4 | 0.95312399 |
| 66 | CDC42BPA | 0.94701108 |
| 67 | PRKD1 | 0.94254361 |
| 68 | TAOK2 | 0.92227577 |
| 69 | PDGFRA | 0.91531775 |
| 70 | GSK3A | 0.90438105 |
| 71 | EEF2K | 0.89247795 |
| 72 | SCYL2 | 0.89082916 |
| 73 | BTK | 0.87587840 |
| 74 | INSRR | 0.86663087 |
| 75 | PAK2 | 0.85463298 |
| 76 | IRAK2 | 0.85128977 |
| 77 | JAK2 | 0.85109189 |
| 78 | TAOK1 | 0.84361828 |
| 79 | HCK | 0.83687219 |
| 80 | PAK3 | 0.80123420 |
| 81 | SGK3 | 0.79427492 |
| 82 | IRAK1 | 0.77693824 |
| 83 | JAK3 | 0.77261197 |
| 84 | STK38 | 0.77239936 |
| 85 | RIPK4 | 0.77188509 |
| 86 | IKBKE | 0.76934501 |
| 87 | SGK494 | 0.75099603 |
| 88 | SGK223 | 0.75099603 |
| 89 | CHUK | 0.72050099 |
| 90 | PAK4 | 0.72036223 |
| 91 | PDPK1 | 0.71594054 |
| 92 | INSR | 0.71115034 |
| 93 | DDR2 | 0.70943240 |
| 94 | TXK | 0.70602900 |
| 95 | CDK12 | 0.70007835 |
| 96 | SMG1 | 0.68652836 |
| 97 | PRKAA2 | 0.67953356 |
| 98 | TRIB3 | 0.67406640 |
| 99 | EGFR | 0.67184700 |
| 100 | SYK | 0.66000848 |
| 101 | MAP3K8 | 0.65809333 |
| 102 | ABL1 | 0.65258071 |
| 103 | PTK2 | 0.63025785 |
| 104 | MAPKAPK5 | 0.62026955 |
| 105 | PTK2B | 0.60562138 |
| 106 | SIK1 | 0.59568093 |
| 107 | HIPK2 | 0.57931715 |
| 108 | MTOR | 0.57827921 |
| 109 | LCK | 0.57347332 |
| 110 | CSNK1A1L | 0.56942714 |
| 111 | MAP2K3 | 0.56391659 |
| 112 | MATK | 0.55068667 |
| 113 | MAP3K7 | 0.52196000 |
| 114 | FYN | 0.51546165 |
| 115 | MAP3K5 | 0.51043443 |
| 116 | MAPK12 | 0.50953747 |
| 117 | LRRK2 | 0.50744887 |
| 118 | NEK6 | 0.50718285 |
| 119 | IGF1R | 0.50294196 |
| 120 | PRKCH | 0.50000544 |
| 121 | MOS | 0.49952750 |
| 122 | SGK2 | 0.49925472 |
| 123 | MAP2K2 | 0.49773713 |
| 124 | GRK6 | 0.49710950 |
| 125 | LYN | 0.48149975 |
| 126 | PRKD2 | 0.47596691 |
| 127 | CDK9 | 0.46943019 |
| 128 | PRKG2 | 0.46265454 |
| 129 | RPS6KA2 | 0.45846358 |
| 130 | MAPK7 | 0.45443576 |
| 131 | PDK1 | 0.45431041 |
| 132 | STK4 | 0.45062614 |
| 133 | MAPKAPK2 | 0.44531405 |
| 134 | PIK3CG | 0.44391984 |
| 135 | MARK3 | 0.44061599 |
| 136 | FGFR4 | 0.43341976 |
| 137 | SGK1 | 0.43232218 |
| 138 | SIK3 | 0.42993784 |
| 139 | MAP2K1 | 0.42725117 |
| 140 | EPHB2 | 0.41655179 |
| 141 | MAP4K1 | 0.41464579 |
| 142 | MST1R | 0.40631171 |
| 143 | PRKCE | 0.39993284 |
| 144 | NTRK1 | 0.39327494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.03369501 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.20308297 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 1.81601422 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79562675 |
| 5 | Malaria_Homo sapiens_hsa05144 | 1.74579411 |
| 6 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.60929166 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 1.57267869 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.55802317 |
| 9 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.46553378 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.45909748 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43486744 |
| 12 | Focal adhesion_Homo sapiens_hsa04510 | 1.41089531 |
| 13 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39834607 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35857770 |
| 15 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.33363276 |
| 16 | Adherens junction_Homo sapiens_hsa04520 | 1.32542084 |
| 17 | Amoebiasis_Homo sapiens_hsa05146 | 1.31097813 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.30944374 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30251589 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.28478685 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.27296945 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.27104707 |
| 23 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.26757823 |
| 24 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.25162334 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.22748958 |
| 26 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.21492111 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20778760 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20593776 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19899452 |
| 30 | Endometrial cancer_Homo sapiens_hsa05213 | 1.19326981 |
| 31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18160403 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17248036 |
| 33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.16786921 |
| 34 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.11540280 |
| 35 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.10951755 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10673287 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.10399079 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08560563 |
| 39 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.08092696 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07455632 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06725141 |
| 42 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.05817312 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05546979 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 1.04507587 |
| 45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04362811 |
| 46 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04091265 |
| 47 | Thyroid cancer_Homo sapiens_hsa05216 | 1.02782992 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.99491795 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.98074498 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97928002 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.97334870 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96947221 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.96843459 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95538186 |
| 55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95153191 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93391490 |
| 57 | Measles_Homo sapiens_hsa05162 | 0.92679661 |
| 58 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.92555981 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.91752823 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.91387724 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89841688 |
| 62 | Prostate cancer_Homo sapiens_hsa05215 | 0.89663073 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89418712 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.89178747 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.87178188 |
| 66 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85111634 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84162249 |
| 68 | Allograft rejection_Homo sapiens_hsa05330 | 0.83794102 |
| 69 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.82464169 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.81767309 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81621989 |
| 72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81126666 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80893090 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80841065 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80652231 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79808747 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77735581 |
| 78 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77407882 |
| 79 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77138797 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76433140 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.76218050 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75836462 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75796752 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.75562343 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75322327 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.73759621 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73665222 |
| 88 | Long-term potentiation_Homo sapiens_hsa04720 | 0.73553758 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73454811 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73182517 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72685391 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72672828 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.72028523 |
| 94 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70814755 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70571626 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70443762 |
| 97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69813362 |
| 98 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69008418 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68584302 |
| 100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.68015118 |
| 101 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.67902583 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67815897 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66667999 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65054651 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.64027922 |
| 106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63883818 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.63140765 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.62771159 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61628813 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.61396887 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60990068 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59906804 |
| 113 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59131368 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58926034 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58392589 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57311186 |
| 117 | Tight junction_Homo sapiens_hsa04530 | 0.55785067 |
| 118 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55629135 |
| 119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55029670 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54755864 |
| 121 | ABC transporters_Homo sapiens_hsa02010 | 0.54578285 |
| 122 | Glioma_Homo sapiens_hsa05214 | 0.54331991 |
| 123 | Asthma_Homo sapiens_hsa05310 | 0.54006560 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53329287 |
| 125 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53259202 |
| 126 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50846495 |
| 127 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50586296 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.50385535 |
| 129 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50033765 |

